18-hydroxycortisol

1.	Walker, B R: 1 article (06/2005)
2.	Wallace, A M: 1 article (06/2005)
3.	Shakerdi, L A: 1 article (06/2005)
4.	Reynolds, R M: 1 article (06/2005)
5.	Sandhu, K: 1 article (06/2005)
6.	Wood, P J: 1 article (06/2005)
7.	Mosso, L: 1 article (09/2001)
8.	Foecking, M F: 1 article (09/2001)
9.	Gómez-Sánchez, C E: 1 article (09/2001)
10.	Fardella, C: 1 article (09/2001)

Related Diseases

1.	Hyperaldosteronism (Conn Syndrome) 09/01/2001 - "This study reports the determination of plasma 18-hydroxycortisol (18-OHF) using a new and easy enzyme-linked immunosorbent assay (ELISA) method in primary aldosteronism and compares the values found in essential hypertensives and normotensive controls" 06/01/2005 - "The utility of three different methods for measuring urinary 18-hydroxycortisol in the differential diagnosis of suspected primary hyperaldosteronism." 10/01/2001 - "The 18-hydroxycortisol levels in the eight idiopathic hyperaldosteronism patients and four controls with chimeric gene were 3.9 +/- 2.3 and 21.9 +/- 3.5 nmol/liter, respectively (P < 0.01)" 08/01/1994 - "Urinary 18-hydroxycortisol measured by the present assay was 153 +/- 119 nmol/L (mean +/- SD, range, 28-485) and 1787 +/- 1180 (range, 810-4264) in normal subjects (n = 20) and in patients with primary aldosteronism (n = 7), respectively" 07/01/1993 - "Urinary 18-hydroxycortisol excretion ranged 836-7460 and 26-696 nmol/24 h, respectively, in patients with primary aldosteronism (n = 8) and in control subjects (n = 40)" Get all the results and reference details, order at left...
2.	Adenoma (Adenomas) 04/01/1993 - "18-Hydroxycortisol excretion similarly separated bilateral hyperplasia (23-59 micrograms/day) from typical adenomas (60-2750 micrograms/day)" 08/01/1987 - "The urinary excretion of 18-hydroxycortisol was recently reported to be increased in patients with primary aldosteronism who have an adrenal adenoma and in those with glucocorticoid-suppressible aldosteronism" 06/01/1985 - "For control subjects, the mean concentrations of 18-hydroxycortisol in urine and plasma were 310 (SD 178) nmol/24 h (n = 32) and 2.27 (SD 0.80) nmol/L (n = 37), respectively; patients with Conn's adenoma or glucocorticoid-remediable aldosteronism had values for urine in the range 1084 to 6534 nmol/24 h and concentrations in plasma ranging from 6.49 to 31.20 nmol/L" 08/01/1997 - "Two of the four patients with adrenal adenoma had high levels of urinary and serum 18-hydroxycortisol and 18-oxocortisol; on the other hand all the patients with adrenal hyperplasia had normal urinary and serum levels of both steroids" 12/01/1994 - "Tests that distinguished adenomas from adrenal hyperplasia included the postural stimulation test, urinary excretion rates of 18-oxocortisol and 18-hydroxycortisol, and adrenal vein sampling." Get all the results and reference details, order at left...
3.	Hypertension (High Blood Pressure) 01/01/1987 - "As 18-hydroxycortisol is inactive, the meaning of this elevated excretion is unclear, but it may be a marker of an adrenal enzymatic abnormality which may be playing a more direct role in hypertension." 01/01/1982 - "Hypersecretion of a new corticosteroid, 18-hydroxycortisol in two types of adrenocortical hypertension." 09/01/2001 - "Serum 18-hydroxycortisol in primary aldosteronism, hypertension, and normotensives." 04/01/1997 - "The increased urinary excretion of 18-hydroxycortisol (18-OHF) in patients with primary aldosteronism has raised the possibility that 18-OHF is involved in the maintenance and/or pathogenesis of the associated hypertension" 01/01/1987 - "Patients with normal renin hypertension excreted 54 +/- 43 micrograms/24 h of 18-hydroxycortisol, those with low renin essential hypertension excreted 58 +/- 54 micrograms/24 h, and normal individuals excreted 63 +/- 36 micrograms/24 h" Get all the results and reference details, order at left...
4.	Hyperplasia 04/01/1993 - "18-Hydroxycortisol excretion similarly separated bilateral hyperplasia (23-59 micrograms/day) from typical adenomas (60-2750 micrograms/day)" 06/01/1985 - "Concentrations of 18-hydroxycortisol in urine clearly discriminate patients with idiopathic hyperplasia from those with other forms of primary aldosteronism, but further work is required to assess the diagnostic accuracy of determinations in plasma." 08/01/1997 - "Two of the four patients with adrenal adenoma had high levels of urinary and serum 18-hydroxycortisol and 18-oxocortisol; on the other hand all the patients with adrenal hyperplasia had normal urinary and serum levels of both steroids" 12/01/1994 - "Tests that distinguished adenomas from adrenal hyperplasia included the postural stimulation test, urinary excretion rates of 18-oxocortisol and 18-hydroxycortisol, and adrenal vein sampling." 06/01/2005 - "OBJECTIVE: Urine 18-hydroxycortisol (18-OHF) measurements are claimed to discriminate between primary hyperaldosteronism due to Conn's syndrome/adrenal adenoma or idiopathic bilateral adrenal hyperplasia (BAH), and also to identify cases of glucocorticoid-suppressible hyperaldosteronism (GSH)" Get all the results and reference details, order at left...
5.	Syndrome 11/01/1985 - "Factors affecting the secretion of 18-hydroxycortisol, a novel steroid of relevance to Conn's syndrome." 08/01/1984 - "In summary, it is unlikely that 18-hydroxycortisol plays a role in the metabolic syndrome in those patients who produce it in excess due to its inactivity as a gluco- or mineralocorticoid." 06/01/2005 - "OBJECTIVE: Urine 18-hydroxycortisol (18-OHF) measurements are claimed to discriminate between primary hyperaldosteronism due to Conn's syndrome/adrenal adenoma or idiopathic bilateral adrenal hyperplasia (BAH), and also to identify cases of glucocorticoid-suppressible hyperaldosteronism (GSH)" Get all the results and reference details, order at left...
8 Diseases and 37 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	18-oxocortisol
2.	Steroids
3.	Dexamethasone (Maxidex)
4.	Aldosterone Synthase (CYP11B2)
5.	Aldosterone
6.	Hydrocortisone (Cortisol)
7.	18-Hydroxycorticosterone (18 Hydroxycorticosterone)
8.	Adrenocorticotropic Hormone (ACTH)
9.	Biological Markers (Surrogate Marker)
10.	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)
19 Drugs and Important Bio-Agents and 25 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Adrenalectomy
1 Therapies and Procedures and 1 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>